Luolifen Holdings Co., Ltd. 2025 Q4 Financials
Luolifen Holdings Co., Ltd. (Company Code: 6666), operating in the Biotechnology and Medical Industry, announced its Q4 2025 financial results. The company reported a basic earnings per share of NTD 2.42, with operating revenue reaching NTD 1.113 billion and net income after tax at NTD 108 million.
📋 Article Processing Timeline
- 📰 Published: December 1, 2025 at 09:00
- 🔍 Collected: April 7, 2026 at 08:00 (3047h 0m after Published)
- 🤖 AI Analyzed: April 8, 2026 at 00:21 (16h 20m after Collected)
Company Code: 6666. Company Name: Luolifen Holdings Co., Ltd. Industry: Biotechnology and Medical Industry. Year/Quarter: 2025 Q4. Basic Earnings Per Share: NTD 2.42. Operating Revenue: NTD 1.113 billion. Net Income After Tax: NTD 108 million.